Risk factors

Xenetic Biosciences (XBIO) risk factors

Item 1A of every Xenetic Biosciences, Inc. 10-K on file, and what changed from one year to the next.

Open XBIO in Gloomberb →
  • FY2025 10-K risk factors

    65 risks, 1 new, 1 reworded since the prior year. Xenetic Biosciences is pursuing strategic alternatives, including a potential business combination or asset sale. The company faces ongoing challenges in meeting Nasdaq listing requirements, underscored by recent meeting adjournments due to a lack of quorum.

    Filed Mar 12, 2026
  • FY2024 10-K risk factors

    64 risks. Xenetic Biosciences is heavily dependent on cash of $6.2 million and external financing to fund operations.

    Filed Mar 18, 2025